[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100489208":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":19,"responsibleParty":43,"collaborators":45,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Liverpool","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with solid organ cancer",null,"Prospective biosampling of blood\u002Ftissue",[13],"Other: Biosampling",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Biosampling","Biosampling of blood\u002Ftumour\u002Fadjacent normal tissue",[9],[20],{"facility":5,"status":21,"city":22,"state":10,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Liverpool","L69 3GB","United Kingdom","UK",{"type":27,"coordinates":28},"Point",[29,30],-2.97794,53.41058,{"lat":30,"lon":29},[33,38,41],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Karen Wilding","CONTACT","07717863747","sponsor@liverpool.ac.uk",{"name":39,"role":40,"phone":10,"phoneExt":10,"email":10},"Robert P Jones","PRINCIPAL_INVESTIGATOR",{"name":42,"role":40,"phone":10,"phoneExt":10,"email":10},"Dale Vimalachandran",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46,48,51,53,55],{"name":47,"class":6},"Countess of Chester NHS Foundation Trust",{"name":49,"class":50},"Liverpool University Hospitals NHS Foundation Trust","OTHER_GOV",{"name":52,"class":6},"Clatterbridge Centre for Oncology",{"name":54,"class":6},"Liverpool Heart and Chest Hospital NHS Foundation Trust",{"name":56,"class":57},"Liverpool Womens Hospital","UNKNOWN","100489208","a-platform-study-for-solid-organ-cancers-100489208",false,"NCT05650125","A Platform Study for solId orgaN CancERs","PINCER (A Platform Study for solId orgaN CancERs); an Agile Regional Platform Study to Deliver High Quality Translational Research","PINCER","Inclusion Criteria:\n\n* Biopsy or surgical resection as standard of care\n\nExclusion Criteria:\n\n* Refusal or inability to consent, paediatric patients",true,"ALL","16 Years","100 Years",{"count":71,"type":72},2000,"ESTIMATED","OBSERVATIONAL","Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.",[76,77],"Cancer","Surgery",[77,76,79,80,81],"Translational","Biosample","Cohort","2025-07-29",{"date":84,"type":85},"2025-08-01","ACTUAL",{"date":87,"type":85},"2022-01-01",{"date":89,"type":72},"2030-01-01",{"name":5,"class":6},1]